Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine plus primaquine versus chloroquine alone for reducing Plasmodium vivax transmission to mosquitoes in adults in southern Ethiopia
PACTR202408837266041Completed
- Sponsor
- University of Bergen
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of chloroquine and primaquine in malaria (2 arms), sponsored by University of Bergen. Primary endpoints: Percentage of mosquitoes with oocyst infection, Oocyst density and 1 more. Started Apr 2022; status: completed.
02
Drugs
chloroquineprimaquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202408837266041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202408837266041.